MedTrace Logo

Bone Marrow Cells With Core Decompression for AVN Treatment

NCT05982054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-07-30

No results posted yet for this study

Summary

Avascular necrosis of the femoral head (AVN) is a progressive pathological process resulting from disruption of blood supply to the femoral head and elevation of intraosseous pressure. total hip arthroplasty is frequently the only durable option for pain relief and restoration of function. this is a single armed study to be done from July 2023 till January 2024, the total number of patients anticipated is 10, total joints treated around 20, The procedure includes core decompression with autologous bone marrow derived mononuclear cell injection inside the femoral head using local anesthesia ultrasound and fluoroscopy guided without drilling.

Conditions

  • Avascular Necrosis of the Femoral Head

Interventions

PROCEDURE

core decompression with local bone marrow mononuclear cells injection

under local anesthesia ,anterior approach, with ultrasound and fluoroscopy guide

Sponsors & Collaborators

  • Global Stem Cell Center, Baghdad

    lead INDUSTRY

Principal Investigators

  • abdulmajeed a hammadi, MD · clinical stem cell studies

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2024-07-28
Completion
2024-07-28

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05982054 on ClinicalTrials.gov